Literature DB >> 24778069

Early metabolic response on 18F-fluorodeoxyglucose-positron-emission tomography/computed tomography after concurrent chemoradiotherapy for advanced stage III non-small cell lung cancer is correlated with local tumor control and survival.

Jae-Uk Jeong1, Woong-Ki Chung, Taek-Keun Nam, Ju-Young Song, Mee Sun Yoon, Young-Chul Kim, Kyu-Sik Kim, In-Jae Oh, Hee-Jung Ban, Seong Young Kwon, Hee-Seung Bom, Sung-Ja Ahn.   

Abstract

AIM: We evaluated the relationship of early metabolic responses on (18)F-fluorodeoxyglucose-positron-emission tomography/computed tomography (PET/CT) performed within one month after concurrent chemoradiotherapy (CCRT) with local tumor control and survival in patients with advanced stage III non-small cell lung cancer (NSCLC). PATIENTS AND METHODS: One hundred and nineteen patients with unresectable stage III NSCLC who completed definitive CCRT were included. PET/CT was performed 2-4 weeks after completion of radiotherapy.
RESULTS: The maximum standardized uptake value (SUVmax) reduction ratio of the primary lesion (primary SRR, 80%, p<0.001), gross tumor volume (150 cm(3), p=0.036), and pre-radiotherapy ratio of SUVmax of the metastatic lymph node to that of the primary lesion (60%, p=0.05) were significantly associated with OS in multivariate analysis. The primary SRR was the only statistically significant parameter for local control.
CONCLUSION: Early metabolic response of the primary lesion after CCRT correlated with local control and overall survival in patients with unresectable stage III NSCLC.

Entities:  

Keywords:  Non-small cell lung cancer; concurrent chemoradiotherapy; metabolic response; prognosis

Mesh:

Substances:

Year:  2014        PMID: 24778069

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Regional Lymph Node Uptake of [(18)F]Fluorodeoxyglucose After Definitive Chemoradiation Therapy Predicts Local-Regional Failure of Locally Advanced Non-Small Cell Lung Cancer: Results of ACRIN 6668/RTOG 0235.

Authors:  Stephanie Markovina; Fenghai Duan; Bradley S Snyder; Barry A Siegel; Mitchell Machtay; Jeffrey D Bradley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-11-01       Impact factor: 7.038

2.  Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer.

Authors:  Yoichi Ohtaki; Kimihiro Shimizu; Kyoichi Kaira; Toshiteru Nagashima; Kai Obayashi; Seshiru Nakazawa; Seiichi Kakegawa; Hitoshi Igai; Mitsuhiro Kamiyoshihara; Masahiko Nishiyama; Izumi Takeyoshi
Journal:  Surg Today       Date:  2016-01-19       Impact factor: 2.549

Review 3.  Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer : A systematic review.

Authors:  Lukas Käsmann; Maximilian Niyazi; Oliver Blanck; Christian Baues; René Baumann; Sophie Dobiasch; Chukwuka Eze; Daniel Fleischmann; Tobias Gauer; Frank A Giordano; Yvonne Goy; Jan Hausmann; Christoph Henkenberens; David Kaul; Lisa Klook; David Krug; Matthias Mäurer; Cédric M Panje; Johannes Rosenbrock; Lisa Sautter; Daniela Schmitt; Christoph Süß; Alexander H Thieme; Maike Trommer-Nestler; Sonia Ziegler; Nadja Ebert; Daniel Medenwald; Christian Ostheimer
Journal:  Strahlenther Onkol       Date:  2017-10-13       Impact factor: 3.621

Review 4.  Role of interim 18F-FDG-PET/CT for the early prediction of clinical outcomes of Non-Small Cell Lung Cancer (NSCLC) during radiotherapy or chemo-radiotherapy. A systematic review.

Authors:  Marta Cremonesi; Laura Gilardi; Mahila Esmeralda Ferrari; Gaia Piperno; Laura Lavinia Travaini; Robert Timmerman; Francesca Botta; Guido Baroni; Chiara Maria Grana; Sara Ronchi; Delia Ciardo; Barbara Alicja Jereczek-Fossa; Cristina Garibaldi; Roberto Orecchia
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-05       Impact factor: 9.236

5.  Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.

Authors:  Jay P Reddy; Chad Tang; Tina Shih; Bumyang Kim; Charissa Kim; Quynh-Nhu Nguyen; James Welsh; Marcelo Benveniste; Jianjun Zhang; Zhongxing Liao; Daniel R Gomez
Journal:  Clin Lung Cancer       Date:  2016-11-10       Impact factor: 4.785

Review 6.  The application of positron emission tomography (PET/CT) in diagnosis of breast cancer. Part II. Diagnosis after treatment initiation, future perspectives.

Authors:  Elżbieta Jodłowska; Rafał Czepczyński; Agata Czarnywojtek; Amanda Rewers; Grażyna Jarząbek; Witold Kędzia; Marek Ruchała
Journal:  Contemp Oncol (Pozn)       Date:  2016-08-04

7.  Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients.

Authors:  Aglaia Schiza; Sandra Irenaeus; Francisco Ortiz-Nieto; Angelica Loskog; Thomas Tötterman; Anders Sundin; Gustav J Ullenhag; Håkan Ahlström
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.